Published • loading... • Updated
FDA Clears First Hepatitis Delta Treatment for U.S. Market
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
FDA Clears First Hepatitis Delta Treatment for U.S. Market
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Hepcludex as the first authorized treatment for chronic hepatitis delta virus infection in the United States, giving patients with the rare but severe liver disease access to a federally approved therapy for the first time. The treatment, developed by Gilead Sciences, was approved for adults with chronic hepatitis delta virus, or HDV, infection who do not have cirrhosis or who hav…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
